Clinical Trial Update: A Cardiac Safety Study of Tivozanib to Evaluate the Electrocardiogram and Pharmacokinetic-Electrocardiogram Dynamics in Subjects With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

This is a Phase 1 cardiac safety trial of tivozanib evaluating ECG and PK-ECG dynamics in subjects with advanced solid tumors; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Tivozanib (tivozanib)

Snippet

Sponsor: AVEO Pharmaceuticals, Inc. | Conditions: Advanced Solid Tumors | Phase 1 | Status: COMPLETED